Perinatal exposure to zidovudine--benefits and risks.
Mofenson
L M
LM
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006352:Heart Ventricles / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008137:Longitudinal Studies; D008929:Mitochondria, Heart / Q000187:drug effects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D037841:Pregnant People; D011295:Prenatal Care; D011297:Prenatal Exposure Delayed Effects; D018570:Risk Assessment; D016277:Ventricular Function, Left / Q000187:drug effects*; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine